#229FUZKK selection 101–300
Polfa Tarchomin
Poland · European Union
Antibiotics and fermentationFinished dosage forms and small molecules
Manufacturing profile
- Country
- Poland
- Regulatory region
- European Union
- ISO
- POL
Selection basis
The company is placed in positions 101–300 as a manufacturer, biotechnology company, generics player or CDMO with practical relevance to the FUZKK utility catalog.
The Top 300 is a FUZKK atlas priority rather than a single official revenue table. The mapping does not claim actual use of FUZKK, a specific installed equipment model or a product not confirmed by the public company profile.
Representative manufacturing and QC chain
- 1Seed preparation and industrial fermentation
- 2Broth clarification and primary recovery
- 3Extraction, crystallisation and purification
- 4Sterile or non-sterile formulation
- 5Potency, impurity profile, bioburden and residual solvents
- 6Raw-material receipt and identification
- 7Dispensing, blending and granulation
- 8Tableting, encapsulation or solution preparation
- 9Packaging and labelling
Relevant FUZKK packages
Product/API utilities
Antibiotic Intermediate Release CheckerAntibiotic Potency Assay CheckerFermentation Impurity Profile AnalyzerFermentation Residual Solvent CheckerFermentation Bioburden Trend CheckerFermentation Yield Consistency CheckerSix APAImpurity Profile CheckerSeven ACAImpurity Profile CheckerAssay & Impurities Result Reviewer
Lumex — instrumental QC
LabEx — laboratory QC
Medical Devices — equipment and software lifecycle
Suggested first pilot
- Confirm one real product, method or recurring QC review.
- Record the instrument, export format and current specification.
- Select 3–7 utilities from the map above.
- Run a PASS/FAIL sample and agree the expected output.
- After user validation, expand to other products and sites.
Mapping boundary
The Top 300 is a FUZKK atlas priority rather than a single official revenue table. The mapping does not claim actual use of FUZKK, a specific installed equipment model or a product not confirmed by the public company profile.
Methodology